semaglutide alcohol use disorder clinical trial Once-Weekly in Adults With Disorder, A Randomized Trial, PMID: 39937469 , https://pubmed.ncbi.nlm.nih.gov/39937469 /, Excessive alcohol use is estimated to account for Can semaglutide help reduce alcohol

call for increased FDA oversight to protect consumers from unapproved formulations marketed outside rigorous regulatory standards

Stengel, A., Wang, L., Goebel-Stengel, M., & Tach, Y

The most likely explanation is that GLP-1 receptor activation on vascular endothelium, atherosclerotic plaques, and inflammatory pathways drives most of the cardio benefit and that benefit doesn't scale linearly with weight loss

"What's different is what the drug actually does for you which is I don't feel like I'm dieting

Treatment with empagliflozin, semaglutide, or their combination with ramipril did not reduce kidney weight or glomerular size (Figures 3A, B)